Prime Minister Mark Carney is playing down the amount of toll profits Canada will share with the United States under a new ...

Joby Aviation has brought its all-electric air taxi to central London in Virgin Atlantic livery, giving the British public its first close-up look at the aircraft that the two companies hope will one ...

In a 6-3 decision, justices voted in favour of birthright citizenship, rejecting an executive order by the president issued at the start of his second term.

Digital Catapult has concluded its inaugural Digital Twin Adoption Accelerator which showcased cutting-edge digital twin ...

An uneasy quiescence has come to define U.S.-Chinese relations during U.S. President Donald Trump’s second term. Although both governments are calling it “constructive strategic stability,” ...

Megan Clark, a clinical pharmacist practitioner with Novant Health’s Heart and Vascular Institute, was in the studio to discuss the disease and treatment options. Three groups have filed ...

WILMINGTON, N.C. (AP) - An experimental pill is providing new hope for patients with advanced pancreatic cancer, one of the deadliest malignancies that often shows no early symptoms, according to the ...

A new type of peptide receptor radionuclide therapy (PRRT) appears to be safe in metastatic neuroendocrine tumor patients who have exhausted conventional treatment options. This novel approach, ...

A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types of cancer. “While not ...

As part of a clinical study, the Early Clinical Trial Unit (ECTU) at NCT/UCC Dresden tested the cancer immunotherapy IMA401 for the first time in patients with advanced solid tumors. IMA401 is a ...

A targeted treatment that triggers the death of cancer cells has shown promise for patients with advanced bowel cancer when used alongside chemotherapy, an early trial has found. The combination ...

For men with advanced prostate cancer that no longer responds to standard hormone therapies, treatment options are limited—and time matters. As the disease progresses, the window for effective, less ...